| Fulvestrant 250 mg solution for injection in pre-filled syringe PA23092/001/001 |
Fulvestrant |
Reddy Holding GmbH |
Not marketed |
| Fulvestrant 250 mg Solution for injection in pre-filled syringe PA2315/046/001 |
Fulvestrant |
Accord Healthcare Ireland Ltd. |
Marketed |
| Fulvestrant EVER Pharma 250 mg solution for injection in pre-filled syringe PA1774/006/001 |
Fulvestrant |
EVER Valinject GmbH |
Marketed |
| Fulvestrant Mylan 250 mg solution for injection in pre-filled syringe EU/1/17/1253/001-002 |
Fulvestrant |
Mylan Pharmaceuticals Limited |
— |
| Fulvestrant Rowex 250 mg/5 ml solution for injection in pre-filled syringe PA0711/245/001 |
Fulvestrant |
Rowex Limited, |
Marketed |
| Fulvestrant Teva 250 mg Solution for Injection in Pre-filled Syringe PA1986/011/001 |
Fulvestrant |
Teva B.V. |
Marketed |
| Fungasil 250 mg tablets PA0126/141/001 |
Terbinafine |
Clonmel Healthcare Ltd |
Marketed |
| Fungizone 50 mg Powder for sterile concentrate PA2239/004/001 |
Amphotericin b |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Furosemide 10 mg/ml Solution for Injection PA2299/036/001 |
Furosemide |
Baxter Holding B.V. |
Not marketed |
| Furosemide 10 mg/ml Solution for Injection or Infusion PA2315/163/001 |
Furosemide |
Accord Healthcare Ireland Ltd. |
Marketed |
| Furosemide 10 mg/ml solution for injection/infusion PA2237/002/001 |
Furosemide |
hameln pharma gmbh |
Not marketed |
| Furosemide 20 mg Tablets PA0126/008/001 |
Furosemide |
Clonmel Healthcare Ltd |
Marketed |
| Furosemide 20 mg/2 ml solution for injection/infusion PA2059/038/001 |
Furosemide |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Furosemide 20mg in 2ml Solution for Injection PA0073/059/004 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Furosemide 250mg in 25ml Solution for Injection/Infusion PA0073/059/006 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Not marketed |
| Furosemide 40 mg Tablets PA0126/008/002 |
Furosemide |
Clonmel Healthcare Ltd |
Marketed |
| Furosemide 50mg in 5ml Solution for Injection PA0073/059/005 |
Furosemide |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Furosemide Bristol 20 mg Tablets PA22749/001/001 |
Furosemide |
Brillpharma (Ireland) Limited |
Marketed |
| Furosemide Bristol 40 mg Tablets PA22749/001/002 |
Furosemide |
Brillpharma (Ireland) Limited |
Marketed |
| Furosemide Clonmel 20 mg tablets PA0126/421/001 |
Furosemide |
Clonmel Healthcare Ltd |
Not marketed |
| Furosemide Clonmel 40 mg tablets PA0126/421/002 |
Furosemide |
Clonmel Healthcare Ltd |
Not marketed |
| Furosemide Pinewood 20 mg Tablets PA0281/263/001 |
Furosemide |
Pinewood Laboratories Ltd |
Marketed |
| Furosemide Pinewood 40 mg Tablets PA0281/263/002 |
Furosemide |
Pinewood Laboratories Ltd |
Marketed |
| Fusidic acid/Betamethasone Bailleul 20 mg/g + 1 mg/g Cream PA25477/001/001 |
Fusidic acid, Betamethasone valerate |
Laboratoires Bailleul S.A. |
Not marketed |
| Fusidic acid/Betamethasone Galenpharma 20+1mg/gram(s) Cream PA23425/001/001 |
Fusidic acid, Betamethasone valerate |
GALENpharma GmbH |
Not marketed |
| Fusidic acid/Betamethasone Laboratoires Medgen 20 mg/g + 1 mg/g Cream PA25250/001/001 |
Fusidic acid, Betamethasone valerate |
Laboratoires Medgen |
Not marketed |
| Fuzeon EU/1/03/252/001 |
Enfuvirtide |
Roche Registration GmbH |
Not marketed |
| Fybogel Citrus 3.5 g Granules PA0979/009/001 |
Ispaghula husks |
Reckitt Benckiser Ireland Limited |
Not marketed |
| Fybogel Mebeverine Granules for Oral Suspension Ispaghula Husk 3.5g Mebeverine Hydrochloride 135mg PA0979/010/001 |
Mebeverine hydrochloride, Ispaghula husks |
Reckitt Benckiser Ireland Limited |
Not marketed |
| Fybogel Orange 3.5 g granules PA0979/009/002 |
Ispaghula husks |
Reckitt Benckiser Ireland Ltd, |
Marketed |
| Fycompa 0.5 mg film-coated tablets EU/1/12/776/024 |
Perampanel |
Eisai GmbH |
— |
| Fycompa 10 mg film-coated tablets EU/1/12/776/011-013 |
Perampanel |
Eisai GmbH |
— |
| Fycompa 12 mg film-coated tablets EU/1/12/776/014-016 |
Perampanel |
Eisai GmbH |
— |
| Fycompa 2 mg film-coated tablets EU/1/12/776/001 |
Perampanel |
Eisai GmbH |
— |
| Fycompa 4 mg film-coated tablets EU/1/12/776/002-004 |
Perampanel |
Eisai GmbH |
— |
| Fycompa 6 mg film-coated tablets EU/1/12/776/005-007 |
Perampanel |
Eisai GmbH |
— |
| Fycompa 8 mg film-coated tablets EU/1/12/776/008-010 |
Perampanel |
Eisai GmbH |
— |
| Fydrane 0.2 mg/ml + 3.1 mg/ml + 10 mg/ml, solution for injection PA1107/012/001 |
Tropicamide, Phenylephrine hydrochloride, Lidocaine Hydrochloride Monohydrate |
Laboratoires Thea |
Marketed |
| Fymskina 130 mg Concentrate for solution for infusion EU/1/24/1862/003 |
Ustekinumab |
Formycon AG |
— |
| Fymskina 45 mg Solution for injection EU/1/24/1862/001 |
Ustekinumab |
Formycon AG |
— |
| Fymskina 90 mg Solution for injection EU/1/24/1862/002 |
Ustekinumab |
Formycon AG |
— |